Multicytokine detection improves latent tuberculosis diagnosis in health care workers

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1711-1717

  Rubbo, Pierre Alain ^a,b,c   Nagot, Nicolas ^a,b,c   Le Moing, Vincent ^c   Brabet, Marylène ^c   Bourdin, Arnaud ^c   Nogué, Erika ^c   Bolloré, Karine ^a,b,c   Vendrell, Jean Pierre ^a,b,c   Van De Perre, Philippe ^a,b,c   Tuaillon, Edouard ^a,b,c  

^a UNIV MONTPELLIER   (France)

^b UMR 1058 University of Montpellier   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 15; INTERLEUKIN 2;

ADULT; AREA UNDER THE CURVE; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; HEALTH CARE PERSONNEL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OCCUPATIONAL DISEASE; PERFORMANCE MEASUREMENT SYSTEM; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTIFERON TUBERCULOSIS GOLD IN TUBE TEST; QUANTITATIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; CYTOKINES; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNOASSAY; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84859956533     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00117-12     Document Type: Article

References (28)

1. Abdalhamid B, et al. 2010. Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. J. Clin. Microbiol. 48:2955-2956.
2. Abramo C, et al. 2006. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect. 8:45-51. (Pubitemid 43139291)
3. Andersen P, Munk ME, Pollock JM, Doherty TM. 2000. Specific immune- based diagnosis of tuberculosis. Lancet 356:1099-1104.
4. Anonymous. 2006. Test de detection de la production d'interféron- gamma pour le diagnostic des infections tuberculeuses. Haute Autorité de Santé, Saint-Denis La Plaine, France. http://www.has-sante.fr/portail/ upload/docs /application/pdf/synthese-detection-de-linterferon-gamma.pdf.
5. Biselli R, et al. 2010. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin. Microbiol. Infect. 16:1282-1284.
6. Denkinger CM, Dheda K, Pai M. 2011. Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin. Microbiol. Infect. 17:806-814.
7. de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. 2009. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch. Intern. Med. 169:179-187.
8. Diel R, et al. 2011. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37:88-99.
9. Fox BD, et al. 2009. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis. Lung 187: 413-419.
10. Frahm M, et al. 2011. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb.) 91:250-256.
11. Joshi R, Reingold AL, Menzies D, Pai M. 2006. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 3:e494.
12. Linas BP, Wong AY, Freedberg KA, and Horsburgh CR, Jr. 2011. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am. J. Respir. Crit. Care Med. 184:590-601.
13. Ling DI, et al. 2011. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur. Respir. J. 38:649-656.
14. Mazurek GH, et al. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection. MMWR Morb. Mortal. Wkly. Rep. 59(RR-5):1-25.
15. Menzies D, Joshi R, Pai M. 2007. Risk of tuberculosis infection and disease associated with work in health care settings. Int. J. Tuberc. Lung Dis. 11:593-605. (Pubitemid 46868618)
16. Pai M, et al. 2006. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am. J. Respir. Crit. Care Med. 174:349-355. (Pubitemid 44156616)
17. Pai M, Zwerling A, Menzies D. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177-184.
18. Pooran A, et al. 2010. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm. Med. 10:7.
19. Ringshausen FC, et al. 2011. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin. Vaccine Immunol. 18:1176-1182.
20. Ruhwald M, et al. 2008. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32:1607-1615.
21. Ruhwald M, et al. 2011. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb.) 91:260-267.
22. Ruhwald M, et al. 2008. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 3:e2858.
23. Sauty A, et al. 1999. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162:3549-3558. (Pubitemid 29313608)
24. Sester M, et al. 2011. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 37:100-111.
25. Tsiouris SJ, et al. 2006. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J. Clin. Microbiol. 44:2844-2850. (Pubitemid 44228579)
26. Waldmann T, Tagaya Y, Bamford R. 1998. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:205-226. (Pubitemid 28102254)
27. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. 2011. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11:343-354.
28. Zwerling A, et al. 2012. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 67:62-70.